Optimization of Tau PET Imaging for Alzheimer's Disease through Deep Learning-Based Image Reconstruction
Optimization of Tau PET Imaging for Alzheimer's Disease through Deep Learning-Based Image Reconstruction
批准号:
10933186
负责人:
Kuang Gong
金额:
$44.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by memory loss, cognitive
impairments, and behavioral disorders. 6.2 million people aged 65 and older are living with AD in the United
States in 2021. Earlier diagnosis of AD holds particular significance as therapies are most effective during the
pre-symptomatic stages before irreversible brain damage has occurred. Tau neurofibrillary tangles (NFTs),
accumulating decades before symptomatic onset, can indicate the pre-symptomatic stages. According to Braak
staging, tau NFTs start from transentorhinal, then spreading to hippocampus and other cortices at later stages.
Detecting tau NFTs during early stages and clearly resolving their patterns is essential for early diagnosis and
treatment monitoring of AD. With recent breakthroughs in tau tracer developments, Positron Emission
Tomography (PET) can detect accumulation of tau NFTs in vivo. However, due to signal-to-noise ratio (SNR)
and resolution limits of PET, accurate recovery of tau retention patterns in thin cortical regions is difficult. This is
especially true for early stages when tau signal is weak. Additionally, recent longitudinal studies show that the
accumulation change of tau deposits detected by PET is around 3 to 6 % per year for the AD group, and less for
the preclinical AD group. This small annual change further challenges the signal detectability of current PET
systems. Furthermore, 18F-MK-6240 is a newly developed tau tracer with higher affinity to tau NFTs and no off-
target bindings near early Braak-staging regions, which makes it highly promising for early AD diagnosis.
However, one issue with 18F-MK-6240 is the off-target bindings in the meninges. Given the thin nature of the
cortical ribbon and its proximity to the meninges, quantitative accuracy of tau accumulation is significantly
compromised. Consequently, there are unmet needs to further improve PET resolution and SNR for tau imaging.
This grant application proposes deep learning (DL)-based image reconstruction methods that can improve the
resolution and signal-to-noise ratio (SNR) of tau imaging. The four specific aims of this proposal are (1) to
develop DL-based static PET image reconstruction; (2) to develop DL-based image reconstruction for dynamic
PET; (3) to develop frameworks that can rapidly produce high-quality parametric images; and (4) to apply the
proposed frameworks to 18F-MK-6240 imaging datasets. We expect the integrated outcome of the specific aims
will be robust and clinically effective frameworks that can generate static and parametric images with improved
resolution and SNR from static and simplified dynamic tau PET imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of Tau PET Imaging for Alzheimer's Disease through Deep Learning-Based Image Reconstruction
-
批准号:10501804
-
项目类别:
-
资助金额:$48.06万
-
财政年份:2022
-
负责人:Kuang Gong
-
依托单位:
Optimization of PET Image Reconstruction for Lesion Detection
-
批准号:10206141
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2020
-
负责人:Kuang Gong
-
依托单位:
Correction of Partial Volume Effects in PET for Alzheimer's Disease Using Unsupervised Deep Learning
-
批准号:9974892
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2020
-
负责人:Kuang Gong
-
依托单位:
Optimization of PET Image Reconstruction for Lesion Detection
-
批准号:10041119
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2020
-
负责人:Kuang Gong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
腹侧海马Calb1神经元tau蛋白聚集在阿尔茨海默样社交记忆障碍中的作用及机制研究
-
批准号:JCZRQNB202600714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
P2X7 受体调控小胶质细胞外泌体分泌参与阿尔茨海默病 tau 病理传播的过程及机制研究
-
批准号:ZCLQN26C0901
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵帅
-
依托单位:
AEP剪切SET参与阿尔茨海默症Tau病变机制研究
-
批准号:JCZRQNB202601061
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于多尺度MD和AI解析阿尔茨海默病Tau蛋白相分离失衡分子机制及靶向构象调控策略
-
批准号:JCZRLH202600201
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
β淀粉样蛋白和tau蛋白同时检测的新方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于MTV-MIL-100纳米酶和CHA/Cas12a自反馈级联信号放大的p-Tau217电化学检测新方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭凌霜
-
依托单位:
基于Tau蛋白寡聚体可视化的Tau蛋白病神经病理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:季斌
-
依托单位:
基于ATTEC技术探讨靶向 α-Syn/tau聚集
体双效降解剂的设计、合成及在帕金森
病变中的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:庞冀燕
-
依托单位:
胆固醇共价修饰tau促进阿尔茨海默病发生的分子机制
-
批准号:JCZRQN202500659
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Tau聚集体诱导小胶质细胞释放Frzb促进Aβ病变的机制研究
-
批准号:JCZRYB202500672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: